[Skip to Content]
[Skip to Content Landing]
January 1, 1997

Guidelines for Treating Erectile Dysfunction Issued

JAMA. 1997;277(1):7-8. doi:10.1001/jama.1997.03540250015007

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


THE AMERICAN Urological Association (AUA) released new guidelines for the treatment of organic erectile dysfunction at the World Meeting on Impotence, held in San Francisco, Calif. The new preferred name of the disorder may in part reflect the need to talk about a once-taboo subject by the millions of men (and their partners) of the "baby boom" generation. Many of these men are now facing the risk of sexual dysfunction from prostate cancer surgery and other age-related health problems.

Based on an extensive medical literature review conducted during the past 6 years by its Erectile Dysfunction Clinical Guidelines Panel, the AUA is recommending 3 different therapies as effective in treating organic erectile dysfunction. The therapies include vacuum constriction devices, vasoactive drug injection therapy, and penile prosthetic implants. The panel also recommends against the use of yohimbine, a commonly prescribed drug, which in controlled studies to date does not appear to